Clinical Trial Update: COVID-19 Antibody Responses In Cystic Fibrosis

View source ↗

Summary

A clinical trial evaluating COVID-19 antibody responses in individuals with Cystic Fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Erasmus Medical Center | Conditions: Cystic Fibrosis | Status: COMPLETED